MedTrace Logo

Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment

NCT01620788 · Status: SUSPENDED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 636

Last updated 2022-07-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical efficacy of indapamide 1.5mg / losartan 50mg and indapamide 1.5mg / losartan 100mg on reduction of blood pressure.

Conditions

Interventions

DRUG

Indapamide / Losartan

1 tablet of Indapamide 1.5mg + Losartan 50mg, oral, a day

DRUG

Indapamide / Losartan

1 tablet of Indapamide 1.5mg + Losartan 100mg, oral, a day

DRUG

Hyzaar®

1 tablet of Hyzaar®, oral, a day

DRUG

Hyzaar®

1 tablet of Hyzaar®, oral, a day

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-27
Primary Completion
2023-07-31
Completion
2023-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01620788 on ClinicalTrials.gov